Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists.

R F Bruns, J W Daly, S H Snyder

    Proceedings of the National Academy of Sciences of the United States of America
    |April 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A combination of benzathine penicillin G and triple sulfonamides in oral therapy of acute upper respiratory tract infections.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Dietary source for skin alkaloids of poison frogs (Dendrobatidae)?

    Journal of chemical ecology·2013
    Same author

    The sodium channel in membranes of electroplax. Binding of batrachotoxinin-a [(3)H]benzoate to particulate preparations from electric eel (electrophorus).

    Neurochemistry international·2010
    Same author

    Caffeine analogs: biomedical impact.

    Cellular and molecular life sciences : CMLS·2007
    Same author

    Alkaloids in bufonid toads (melanophryniscus): temporal and geographic determinants for two argentinian species.

    Journal of chemical ecology·2007
    Same author

    A siphonotid millipede (Rhinotus) as the source of spiropyrrolizidine oximes of dendrobatid frogs.

    Journal of chemical ecology·2004

    Researchers designed potent adenosine receptor antagonists by analyzing alkylxanthine structures. A novel compound, 1,3-dipropyl-8-(2-amino-4-chlorophenyl) xanthine, exhibits extraordinary receptor affinity, significantly outperforming existing xanthines.

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Biochemistry

    Background:

    • Adenosine receptors play crucial roles in various physiological processes.
    • Alkylxanthine derivatives have been investigated for their potential as adenosine receptor modulators.
    • Structure-activity relationships are key to designing selective and potent receptor ligands.

    Purpose of the Study:

    • To design and synthesize novel alkylxanthine derivatives with enhanced potency as adenosine receptor antagonists.
    • To investigate the structure-activity relationships of substituted xanthines at adenosine receptor binding sites.
    • To identify compounds with significantly higher affinity for adenosine receptors compared to existing drugs.

    Main Methods:

    • Structure-activity analysis of alkylxanthine derivatives.

    Related Experiment Videos

  • Measurement of receptor affinities by inhibiting the binding of N6-[3H]cyclohexyladenosine to bovine brain membranes.
  • Systematic modification of xanthine substituents to optimize receptor binding.

    • Main Results:

    • 1,3-Dipropyl substitutions at the xanthine core significantly increased potency compared to 1,3-dimethyl substitutions.
    • An 8-phenyl substituent, particularly with para substitutions, markedly enhanced antagonist potency.
    • The compound 1,3-dipropyl-8-(2-amino-4-chlorophenyl) xanthine demonstrated exceptional affinity (Ki = 22 pM) for adenosine A1 receptors.

    Conclusions:

    • Specific structural modifications, including 1,3-dipropyl and substituted 8-phenyl groups, are critical for developing potent adenosine receptor antagonists.
    • The synthesized compound represents a significant advancement in the design of high-affinity ligands for adenosine receptors.
    • This research provides a foundation for developing novel therapeutics targeting adenosine receptor-mediated pathways.